Surprisingly, when SIgAD patients are receiving transfusions with blood or antibody-containing blood products, there are a small number of SIgAD patients that subsequently produce IgG or IgE antibodies against the IgA antibodies present in these transfusions. Here, CD79A is linked to selective IgA deficiency disease.